The side effects were reported on April 1. The medical regulator reported 22 cases of blood clots of cerebral venous sinuses of the brain and other eight cases related to blood clots after the vaccination.
Since the beginning of the vaccination campaign, 18.1 million doses of the AstraZeneca vaccine were used in the UK.
Meanwhile, such reports were not received after the use of the vaccines produced by BioNTech SE and Pfizer Inc.
Previously, due to the blood clots, some countries stopped the use of the AstraZeneca vaccine - particularly, Denmark, Austria, Estonia, Lithuania, Luxembourg, Latvia and Cyprus. Norway, not an EU member also stopped the use of AstraZeneca. Later, Bulgaria, Thailand and Romania joined this list. Soon, Ireland and the Netherlands also refused from AstraZeneca’s use.
Germany, France and Italy also confirmed the refusal of the AstraZeneca vaccine.
In Norway, three medics were hospitalized with blood clots. While a woman died after AstraZeneca shot in Croatia. In Spain, a 43-year-old teacher, who had never pathologies earlier, was vaccinated by AstraZeneca and died from cerebral hemorrhage.
As of now, Canada does not vaccinate people under the age of 55 with AstraZeneca. According to Vice-chair of the NACI Shelley Deeks, there is substantial uncertainty about the benefit of providing AstraZeneca Covid-19 vaccines to adults under 55 given the potential risks.
At the end of March, AstraZeneca vaccine was renamed as Vaxzervia.